Joseph Inigo is a lecturer in the MS Biotechnology program at Northeastern University. He received his PhD in Pharmacology and Cancer Therapeutics from the University at Buffalo, Roswell Park Comprehensive Cancer Center. His research studies included identification of mitochondrial targets for cancer therapy, small molecule drug discovery, and development of genetically engineered mouse models of cancer.
Joseph has experience as a scientist in biotech, developing non-viral gene therapy for hematologic diseases. He also has experience in Business Development, conducting competitive intelligence research to guide pipeline strategy.